Clinical Pharmacokinetics of Upadacitinib: Review of Data Relevant to the Rheumatoid Arthritis Indication

Clinical Pharmacokinetics - United Kingdom
doi 10.1007/s40262-019-00855-0
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Upadacitinib and Filgotinib: The Role of JAK1 Selective Inhibition in the Treatment of Rheumatoid Arthritis

Drugs in Context
Molecular MedicinePharmacology
2019English

Upadacitinib and Filgotinib: The Role of JAK1 Selective Inhibition in the Treatment of Rheumatoid Arthritis

Drugs in Context
Molecular MedicinePharmacology
2019English

Clinical Application of Transfer Factor to Juvenile Rheumatoid Arthritis and Rheumatoid Arthritis in a Adult

The KITAKANTO Medical Journal
1976English

Pharmacokinetics of Dexamethasone in a Rat Model of Rheumatoid Arthritis

Biopharmaceutics and Drug Disposition
MedicinePharmacologyPharmaceutical Science
2008English

Erratum to Clinical Use of Cyclosporin in Rheumatoid Arthritis

Drugs
Pharmacology
1996English

Clinical Pharmacokinetics of Ketoprofen Enantiomers in Wild Type of Cyp 2c8 and Cyp 2c9 Patients With Rheumatoid Arthritis

European Journal of Drug Metabolism and Pharmacokinetics
Pharmacology
2011English

The Clinical Role of Glucocorticoids in the Management of Rheumatoid Arthritis

2012English

The Spectrum and Clinical Significance of Autoantibodies in Rheumatoid Arthritis

Frontiers in Immunology
AllergyImmunology
2015English

Exposure‐Response Analyses of Upadacitinib Efficacy and Safety in Phase 2 and 3 Studies to Support Benefit‐Risk Assessment in Rheumatoid Arthritis

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy